Biotage

Biotage Financial Leverage

Delisted

The Financial Leverage (Equity Multiplier) of Biotage (BIOT.ST) as of Oct 20, 2026 is 1.24. In the previous year, Financial Leverage (Equity Multiplier) was 1.35 — a change of -7.97% (lower).

Financial Leverage

1.24

YoY

-7.97%

Last updated:

Financial Leverage (Equity Multiplier) of Biotage is 2024 1.24 . Financial Leverage (Equity Multiplier) of Biotage was 2023 1.35 . It decreases by -7.97% lower compared to the previous year.

The Biotage Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2017
1.24 SEK
Jan 1, 2018
1.43 SEK
Jan 1, 2019
1.53 SEK
Jan 1, 2020
1.45 SEK
Jan 1, 2021
1.45 SEK
Jan 1, 2022
1.43 SEK
Jan 1, 2023
1.35 SEK
Jan 1, 2024
1.24 SEK
The Biotage Financial Leverage history
YEARFinancial LeverageYoY
1.24-7.97%
1.35-5.63%
1.43-1.59%
1.45+0.21%
1.45-5.03%
1.53+6.78%
1.43+14.83%
1.24+0.80%
1.23+0.88%
1.22-0.65%
1.23—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Biotage Stock analysis

What does Biotage do? Biotage AB is a Swedish company founded in 1983. Since then, the company has become an international leader in the development, manufacturing, and marketing of equipment, chemicals, and accessories for organic and medicinal chemistry, pharmacy, biochemistry, and food analysis. The company's business model is based on the development and marketing of innovative instruments and technologies for analytics and chromatography. Consumables and accessory products are also an important part of the business model. Biotage offers customized solutions tailored to each customer's specific needs. Biotage systems are widely used in the pharmaceutical, biotech, and academic sectors. The company is divided into four main divisions: chromatography, spectroscopy, analytics, and synthesis. In the chromatography division, Biotage offers a wide range of systems for sample preparation and analysis, including flash chromatography systems, HPLC systems, and automation solutions for column development. In the spectroscopy division, Biotage offers systems for molecular structure determination, including NMR spectrometers and FT-IR spectrometers. In the analytics division, the company specializes in mass spectrometry and offers a wide range of instruments and accessories, including HPLC-MS systems, MALDI-TOF systems, and LC-MS applications. In the synthesis division, the focus is on the development and marketing of tools for the synthesis, purification, and analysis of peptides and synthesis kits. Biotage is also known for its wide range of chemicals and accessory products. The company offers a variety of solvents, catalysts, reagents, and separation columns that can be used in organic, pharmaceutical, and biological synthesis. Accessory products include items such as activated carbon filter cartridges or membranes for various chromatography systems. Despite the wide range of products, Biotage has focused on specialized markets, particularly drug research and development, peptide synthesis, and the production of specialty chemicals. In these markets, the devices and chemicals are used to develop and produce medications and important blockbuster compounds. In conclusion, Biotage is a company that focuses on the development and marketing of instruments and technologies for analytics and chromatography. Thanks to its strong market presence and innovative products, the company has become an internationally recognized manufacturer. Biotage is headquartered in Sweden, but its global network of sales and service centers enables global presence and development. Biotage is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Biotage stock

Financial Leverage (Equity Multiplier) of Biotage is 1.24 in 2024.

Financial Leverage (Equity Multiplier) of Biotage changed from 1.35 to 1.24, representing a -7.97% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) Biotage since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s Biotage with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Biotage

All Key Metrics — Biotage